Phase I Clinical Trial of Anlotinib in Progressive, Recurrent, and Refractory Sarcoma in Children
Latest Information Update: 07 Jul 2023
At a glance
- Drugs Catequentinib (Primary)
- Indications Sarcoma
- Focus Adverse reactions
- 06 Jun 2023 Results presented at the 59th Annual Meeting of the American Society of Clinical Oncology.
- 05 Jan 2023 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently (last verified Jan 2021).
- 17 Dec 2020 New trial record